Funding for this research was provided by:
Advanced Accelerator Applications, a Novartis company
Article History
Accepted: 5 June 2021
First Online: 14 July 2021
Declarations
:
: PHMR received financial support from Advanced Accelerator Application, a Novartis company, for conducting the study, including data analysis and preparation of the manuscript.
: A. Soare, and Dr L. Longworth are full-time employees at PHMR. PHMR received financial support from Advanced Accelerator Application, a Novartis company, for the work, including data analysis and preparation of the manuscript. Oscar Leeuwenkamp is a full-time employee of Advanced Accelerator Application, a Novartis company, which funded the work.
: Not applicable (reanalysis of existing datasets based on studies that have previously received ethical approvals).
: Not applicable (reanalysis of existing datasets based on studies that have previously received ethical approvals).
: Not available.
: Not available.
: Not applicable.
: AS: led the drafting of the manuscript, contributed to the analysis, study design and interpretation. OL: contributed to the study design, interpretation and drafting of the manuscript. LL: led the study design and interpretation, contributed to the analysis and drafting of the manuscript. Oversight of the project.